MENU
MREO
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Mereo BioPharma Group (MREO) Earnings Date & Reports
Mereo BioPharma Group PLC is a United Kingdom (U... Show more
A.I. Advisor
published Earnings
MREO is expected to report earnings to rise 41.00% to -1 cents per share on August 18
Q2'26
Est.
$-0.01
Q1'26
Est.
$-0.01
Q4'25
Est.
$-0.01
Q3'25
Missed
by $0.02
Q2'25
Est.
$-0.02
The last earnings report on May 12 showed earnings per share of 0 cents, meeting the estimate of 0 cents. With 1.14M shares outstanding, the current market capitalization sits at 52.15M.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information
General Information
a company, which engages in therapeutics that aim to improve outcomes for patients with osteogenesis imperfecta, alpha-1 antitrypsin deficiency, hypogonadotropic hypogonadism in obese men, and acute exacerbations of chronic obstructive pulmonary disease
Industry Biotechnology
Profile
Details
Industry
N/A
Address
One Cavendish Place
Phone
+44 3330237300
Employees
39
Web
https://www.mereobiopharma.com